Beam Therapeutics, Inc. (BEAM)
24.23
-0.43
(-1.74%)
USD |
NASDAQ |
Apr 06, 16:00
24.22
-0.01
(-0.04%)
After-Hours: 20:00
Beam Therapeutics SG&A Expense (TTM) : 113.82M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 260.54M |
| Intellia Therapeutics, Inc. | 119.80M |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| Pacific Biosciences of California, Inc. | 141.49M |
| Tempus AI, Inc. | 731.74M |